JP2024506847A5 - - Google Patents
Info
- Publication number
- JP2024506847A5 JP2024506847A5 JP2023546266A JP2023546266A JP2024506847A5 JP 2024506847 A5 JP2024506847 A5 JP 2024506847A5 JP 2023546266 A JP2023546266 A JP 2023546266A JP 2023546266 A JP2023546266 A JP 2023546266A JP 2024506847 A5 JP2024506847 A5 JP 2024506847A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025015025A JP2025065209A (ja) | 2021-02-01 | 2025-01-31 | がんを処置および改善するための方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163144378P | 2021-02-01 | 2021-02-01 | |
| US63/144,378 | 2021-02-01 | ||
| PCT/US2022/014663 WO2022165398A1 (en) | 2021-02-01 | 2022-02-01 | Methods for treating and ameliorating cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025015025A Division JP2025065209A (ja) | 2021-02-01 | 2025-01-31 | がんを処置および改善するための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024506847A JP2024506847A (ja) | 2024-02-15 |
| JP2024506847A5 true JP2024506847A5 (https=) | 2025-02-10 |
| JPWO2022165398A5 JPWO2022165398A5 (https=) | 2025-02-10 |
Family
ID=82654982
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023546266A Pending JP2024506847A (ja) | 2021-02-01 | 2022-02-01 | がんを処置および改善するための方法 |
| JP2025015025A Pending JP2025065209A (ja) | 2021-02-01 | 2025-01-31 | がんを処置および改善するための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025015025A Pending JP2025065209A (ja) | 2021-02-01 | 2025-01-31 | がんを処置および改善するための方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240148688A1 (https=) |
| EP (1) | EP4284519A4 (https=) |
| JP (2) | JP2024506847A (https=) |
| CN (1) | CN116829142A (https=) |
| AU (1) | AU2022214463A1 (https=) |
| CA (1) | CA3206959A1 (https=) |
| WO (1) | WO2022165398A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024254465A2 (en) * | 2023-06-09 | 2024-12-12 | The Regents Of The University Of California | Methods for promoting expansion of human cd34+ cells in vivo and for promoting neural regeneration |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04352783A (ja) * | 1991-05-27 | 1992-12-07 | Taisho Pharmaceut Co Ltd | １２員環マクロライド系化合物 |
| US5846743A (en) | 1995-02-22 | 1998-12-08 | Brigham And Women's Hospital, Inc. | Polyphoshoinositide binding peptides for intracellular drug delivery |
| US6589503B1 (en) | 1998-06-20 | 2003-07-08 | Washington University | Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| US20040151766A1 (en) | 2003-01-30 | 2004-08-05 | Monahan Sean D. | Protein and peptide delivery to mammalian cells in vitro |
| WO2005063156A1 (en) | 2003-12-22 | 2005-07-14 | Shear/Kershman Laboratories, Inc. | Oral peptide delivery system with improved bioavailability |
| JP3903061B2 (ja) | 2003-12-24 | 2007-04-11 | 株式会社Ｌｔｔバイオファーマ | 薬物を含有するナノ粒子およびその製造方法、ならびに当該ナノ粒子からなる非経口投与用製剤 |
| US8658203B2 (en) | 2004-05-03 | 2014-02-25 | Merrimack Pharmaceuticals, Inc. | Liposomes useful for drug delivery to the brain |
| JP4758915B2 (ja) | 2004-08-06 | 2011-08-31 | バイオスペクトラム，インコーポレイテッド | 多重層リポソームおよびその製造方法 |
| ATE493444T1 (de) | 2004-10-18 | 2011-01-15 | Nitto Denko Corp | Intrazelluläre peptidabgabe |
| US9005654B2 (en) | 2005-07-27 | 2015-04-14 | Protiva Biotherapeutics, Inc. | Systems and methods for manufacturing liposomes |
| WO2007110704A2 (en) * | 2005-09-28 | 2007-10-04 | Novimmune Sa | Macrolide compositions as therapeutic agent |
| SG10201903112WA (en) * | 2013-04-08 | 2019-05-30 | Berg Llc | Treatment of cancer using coenzyme q10 combination therapies |
| US10675267B2 (en) * | 2015-09-23 | 2020-06-09 | The Regents Of The University Of California | Methods for detection and eradication of myeloid leukemia stem cells |
| WO2019148101A1 (en) | 2018-01-29 | 2019-08-01 | Modernatx, Inc. | Rsv rna vaccines |
| JP2024504367A (ja) * | 2021-01-22 | 2024-01-31 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | がんを治療及び改善するための方法 |
-
2022
- 2022-02-01 WO PCT/US2022/014663 patent/WO2022165398A1/en not_active Ceased
- 2022-02-01 CA CA3206959A patent/CA3206959A1/en active Pending
- 2022-02-01 EP EP22746855.0A patent/EP4284519A4/en active Pending
- 2022-02-01 CN CN202280012882.6A patent/CN116829142A/zh active Pending
- 2022-02-01 US US18/275,388 patent/US20240148688A1/en active Pending
- 2022-02-01 AU AU2022214463A patent/AU2022214463A1/en active Pending
- 2022-02-01 JP JP2023546266A patent/JP2024506847A/ja active Pending
-
2025
- 2025-01-31 JP JP2025015025A patent/JP2025065209A/ja active Pending